The immunopathogenesis of narcolepsy type 1

RS Liblau, D Latorre, BR Kornum… - Nature Reviews …, 2024 - nature.com
Abstract Narcolepsy type 1 (NT1) is a chronic sleep disorder resulting from the loss of a
small population of hypothalamic neurons that produce wake-promoting hypocretin (HCRT; …

Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges

Y Fang, J Ni, YS Wang, Y Zhao, LQ Jiang, C Chen… - Autoimmunity …, 2023 - Elsevier
Exosomes are spherical lipid bilayer vesicles composed of lipids, proteins and nucleic acids
that deliver signaling molecules through a vesicular transport system to regulate the function …

Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial

J Hahn, NR Cook, EK Alexander, S Friedman, J Walter… - Bmj, 2022 - bmj.com
Objective To investigate whether vitamin D and marine derived long chain omega 3 fatty
acids reduce autoimmune disease risk. Design Vitamin D and omega 3 trial (VITAL), a …

Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019

F Cao, YS He, Y Wang, CK Zha, JM Lu, LM Tao… - Autoimmunity …, 2023 - Elsevier
Aim To describe burden, and to explore cross-country inequalities across sociodemographic
development levels for four autoimmune diseases (ADs) including rheumatoid arthritis (RA) …

Antinuclear autoantibodies in health: autoimmunity is not a synonym of autoimmune disease

IA Pashnina, IM Krivolapova, TV Fedotkina… - Antibodies, 2021 - mdpi.com
The incidence of autoimmune diseases is increasing. Antinuclear antibody (ANA) testing is a
critical tool for their diagnosis. However, ANA prevalence in healthy persons has increased …

Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

M Scherlinger, P Mertz, F Sagez, A Meyer, R Felten… - Autoimmunity …, 2020 - Elsevier
Aim To describe changes in the 2001–2014 mortality of 6 autoimmune systemic diseases
(AISDs), namely Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), Idiopathic …

Efficacy and Safety of Mesenchymal Stem Cell Transplantation in the Treatment of Autoimmune Diseases (Rheumatoid Arthritis, Systemic Lupus Erythematosus …

L Zeng, G Yu, K Yang, W Xiang, J Li… - Stem cells …, 2022 - Wiley Online Library
Objective. To evaluate the efficacy and safety of mesenchymal stem cell (MSC)
transplantation in the treatment of autoimmune diseases. Methods. The Chinese and …

[HTML][HTML] Factors predisposing to humoral autoimmunity against brain-antigens in health and disease: Analysis of 49 autoantibodies in over 7000 subjects

VD Gastaldi, JBH Wilke, CA Weidinger, C Walter… - Brain, Behavior, and …, 2023 - Elsevier
Background Circulating autoantibodies (AB) against brain-antigens, often deemed
pathological, receive increasing attention. We assessed predispositions and …

Evaluation of pulmonary fibrosis outcomes by race and ethnicity in US adults

A Adegunsoye, E Freiheit, EN White, B Kaul… - JAMA Network …, 2023 - jamanetwork.com
Importance Pulmonary fibrosis (PF) is characterized by progressive scarring of lung tissue
and poor survival. Racial and ethnic minority populations face the greatest risk of morbidity …

Disease-specific health disparities: a targeted review focusing on race and ethnicity

MR Cullen, AR Lemeshow, LJ Russo, DM Barnes… - Healthcare, 2022 - mdpi.com
Background: Wide disparities in health status exist in the United States across race and
ethnicity, broadly driven by social determinants of health—most notably race and ethnic …